Literature DB >> 24325963

Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans.

Romel D Mackelprang1, Abigail W Bigham, Connie Celum, Guy de Bruyn, Kristin Beima-Sofie, Grace John-Stewart, Allan Ronald, Nelly R Mugo, Kati J Buckingham, Michael J Bamshad, James I Mullins, M Juliana McElrath, Jairam R Lingappa.   

Abstract

OBJECTIVE: We evaluated Toll-like receptors (TLRs) single nucleotide polymorphisms (SNPs) for associations with HIV-1 acquisition, set-point and disease progression in African couples.
METHODS: Seven candidate and 116 haplotype-tagging SNPs (tagSNPs) were genotyped in 504 HIV-1 infected cases, and 343 seronegative controls.
RESULTS: TLR9 1635A/G was associated with reduced HIV-1 acquisition among HIV-seronegative controls with high but not low HIV-1 exposure (odds ratio [OR] = 0.7; P = .03 and OR = 0.9, P = .5, respectively). TLR7 rs179012 and TLR2 597C/T reduced set-point; the latter modified by time since HIV-1 acquisition. TLR8 1A/G reduced disease progression.
CONCLUSIONS: TLR SNPs impact HIV-1 outcomes with epidemiologic factors modifying these relationships.

Entities:  

Keywords:  Acute Infection; Genetics; HIV-1 acquisition; HIV-1 set-point; Heterosexual HIV-1 transmission; Progression; Risk Factors; Toll-like Receptors; Viral load

Mesh:

Substances:

Year:  2013        PMID: 24325963      PMCID: PMC3997584          DOI: 10.1093/infdis/jit807

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.

Authors:  Elena Martinelli; Claudia Cicala; Donald Van Ryk; Diana J Goode; Katilyn Macleod; James Arthos; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

2.  Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection.

Authors:  J Judy Chang; Aurore Lacas; Robert J Lindsay; Erin H Doyle; Karen L Axten; Florencia Pereyra; Eric S Rosenberg; Bruce D Walker; Todd M Allen; Marcus Altfeld
Journal:  AIDS       Date:  2012-03-13       Impact factor: 4.177

3.  Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.

Authors:  Slavé Petrovski; Jacques Fellay; Kevin V Shianna; Nicole Carpenetti; Johnstone Kumwenda; Gift Kamanga; Deborah D Kamwendo; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Myron S Cohen; David B Goldstein
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

4.  Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.

Authors:  Pierre-Yves Bochud; Martin Hersberger; Patrick Taffé; Murielle Bochud; Catherine M Stein; Stephanie D Rodrigues; Thierry Calandra; Patrick Francioli; Amalio Telenti; Roberto F Speck; Alan Aderem
Journal:  AIDS       Date:  2007-02-19       Impact factor: 4.177

5.  Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  Elisabetta Ricci; Sandro Malacrida; Marisa Zanchetta; Ilaria Mosconi; Marco Montagna; Carlo Giaquinto; Anita De Rossi
Journal:  J Transl Med       Date:  2010-05-25       Impact factor: 5.531

Review 6.  Microbial translocation in HIV infection: causes, consequences and treatment opportunities.

Authors:  Netanya G Sandler; Daniel C Douek
Journal:  Nat Rev Microbiol       Date:  2012-08-13       Impact factor: 60.633

7.  A functional toll-like receptor 8 variant is associated with HIV disease restriction.

Authors:  D-Y Oh; S Taube; O Hamouda; C Kücherer; G Poggensee; H Jessen; J K Eckert; K Neumann; A Storek; M Pouliot; P Borgeat; N Oh; E Schreier; A Pruss; K Hattermann; R R Schumann
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

8.  Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1.

Authors:  Romel D Mackelprang; Jared M Baeten; Deborah Donnell; Connie Celum; Carey Farquhar; Guy de Bruyn; Max Essex; M Juliana McElrath; Edith Nakku-Joloba; Jairam R Lingappa
Journal:  J Infect Dis       Date:  2012-08-27       Impact factor: 5.226

9.  Toll-like receptor variants are associated with infant HIV-1 acquisition and peak plasma HIV-1 RNA level.

Authors:  Kristin M Beima-Sofie; Abigail W Bigham; Jairam R Lingappa; Dalton Wamalwa; Romel D Mackelprang; Michael J Bamshad; Elizabeth Maleche-Obimbo; Barbra A Richardson; Grace C John-Stewart
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177

10.  Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.

Authors:  Jairam R Lingappa; Slavé Petrovski; Erin Kahle; Jacques Fellay; Kevin Shianna; M Juliana McElrath; Katherine K Thomas; Jared M Baeten; Connie Celum; Anna Wald; Guy de Bruyn; James I Mullins; Edith Nakku-Joloba; Carey Farquhar; Max Essex; Deborah Donnell; James Kiarie; Bart Haynes; David Goldstein
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

View more
  14 in total

1.  TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women.

Authors:  Pascal Azar; José Enrique Mejía; Claire Cenac; Arnoo Shaiykova; Ali Youness; Sophie Laffont; Asma Essat; Jacques Izopet; Caroline Passaes; Michaela Müller-Trutwin; Pierre Delobel; Laurence Meyer; Jean-Charles Guéry
Journal:  JCI Insight       Date:  2020-06-18

Review 2.  Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots.

Authors:  Rajeev K Mehlotra
Journal:  Curr HIV/AIDS Rep       Date:  2018-12       Impact factor: 5.071

3.  Sensing the hybrid--a novel PAMP for TLR9.

Authors:  Søren B Jensen; Søren R Paludan
Journal:  EMBO J       Date:  2014-02-12       Impact factor: 11.598

4.  A preliminary assessment of Toll-like receptor and β-defensin gene polymorphisms in Papua New Guinea - what does it mean for HIV/AIDS?

Authors:  Barne Willie; Janet Gare; Christopher L King; Peter A Zimmerman; Rajeev K Mehlotra
Journal:  P N G Med J       Date:  2017 Mar-Jun

5.  Toll-like receptor 9 polymorphism is associated with increased Epstein-Barr virus and Cytomegalovirus acquisition in HIV-exposed infants.

Authors:  Kristin Beima-Sofie; Dalton Wamalwa; Elizabeth Maleche-Obimbo; Jairam R Lingappa; Romel Mackelprang; Soren Gantt; Grace John-Stewart; Corey Casper; Jennifer A Slyker
Journal:  AIDS       Date:  2018-01-14       Impact factor: 4.177

6.  Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.

Authors:  Romel D Mackelprang; Mary Carrington; Katherine K Thomas; James P Hughes; Jared M Baeten; Anna Wald; Carey Farquhar; Kenneth Fife; Mary S Campbell; Saida Kapiga; Xiaojiang Gao; James I Mullins; Jairam R Lingappa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  p21(WAF1/CIP1) RNA expression in highly HIV-1 exposed, uninfected individuals.

Authors:  Joshua Herbeck; Suvankar Ghorai; Lennie Chen; Charles R Rinaldo; Joseph B Margolick; Roger Detels; Lisa Jacobson; Steven Wolinsky; James I Mullins
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

8.  Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women.

Authors:  Romel D Mackelprang; Caitlin Wright Scoville; Craig R Cohen; Raphael Omusebe Ondondo; Abigail W Bigham; Connie Celum; Mary S Campbell; Max Essex; Anna Wald; James Kiarie; Allan Ronald; Glenda Gray; Jairam R Lingappa
Journal:  Genes Immun       Date:  2015-04-30       Impact factor: 2.676

9.  Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA.

Authors:  Fu-Chun Yang; Wen-Dong Kuang; Chuan Li; Wei-Wei Sun; Di Qu; Jian-Hua Wang
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

10.  HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation.

Authors:  Bethany M Henrick; Xiao-Dan Yao; Kenneth Lee Rosenthal
Journal:  Front Immunol       Date:  2015-08-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.